First New Oral Class of HIV Medicine in Over a Decade Launched
Pfizer’s Celsentri (maraviroc), an important new HIV medicine and the first new oral class of HIV treatment in more than a decade, has been made available for treatment experienced patients in the UK. Discovered and developed by Pfizer scientists in Sandwich, Kent, maraviroc represents a significant innovation in the treatment of HIV infection. [more...]
|
|
|
